久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • SRI, Sanofi Enter Drug Discovery Collaboration contractpharma
    July 08, 2021
    Will leverage SynFini, SRI’s artificial intelligence and automation platform to accelerate development of small-molecule drug targets.
  • Iktos and SRI to use AI for Covid-19 drug development pharmaceutical-technology
    March 05, 2020
    Artificial intelligence (AI) technology provider Iktos and research centre SRI International have partnered to discover and develop drugs to treat various viruses, including the novel coronavirus that causes Covid-19 and influenza.
  • Q BioMed, SRI Enter ASD Collaboration contractpharma
    December 17, 2018
    Q Inc.?has entered?a collaborative agreement with?SRI International?to provide formulation development, preclinical development, and early clinical manufacturing of
PharmaSources Customer Service